One of the nations with the world’s harshest drug legal guidelines is planning to take a position in medicinal pot.
Singapore’s National Research Foundation (NRF) this month (Jan. 10) introduced that it might develop artificial cannabinoids, or chemical compounds discovered in the marijuana plant, as a part of a broader S$25 million ($19 million) funding by the physique into artificial biology. The initiative will assist increase Singapore’s push to develop a “bio-based economy,” and develop new industries and create jobs in a sustainable means.
The NRF, which is affiliated with the National University of Singapore, stated it plans to supply strains of medicinal cannabinoids derived from the hashish plant for therapeutic functions referring to illnesses resembling Alzheimer’s and Parkinson’s. Cannabinoids embrace tetrahydrocannabinol (THC, the psychoactive factor of weed) and cannabidiol (CBD, which is used for ache aid and produces no excessive).
– Read all the article at Quartz.